Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode.

Koizumi Y, Hirooka M, Tamaki N, Yada N, Nakashima O, Izumi N, Kudo M, Hiasa Y.

PLoS One. 2019 Aug 27;14(8):e0221548. doi: 10.1371/journal.pone.0221548. eCollection 2019.

2.

Programmed death-ligand 1 expression is an unfavorable prognostic factor of hepatocellular carcinoma after archiving sustained virologic response for hepatitis C virus infection.

Kondo R, Akiba J, Ogasawara S, Nakashima O, Naito Y, Kusano H, Mihara Y, Tanigawa M, Yano H.

Oncol Lett. 2019 Aug;18(2):1458-1466. doi: 10.3892/ol.2019.10448. Epub 2019 Jun 7.

3.

Sinusoidal Obstruction Syndrome and Postoperative Complications Resulting from Preoperative Chemotherapy for Colorectal Cancer Liver Metastasis.

Hisaka T, Ishikawa H, Sakai H, Kawahara R, Goto Y, Nomura Y, Yasunaga M, Kinugasa T, Fujita F, Mizobe T, Fukahori M, Miwa K, Nakashima O, Tanigawa M, Naito Y, Akiba J, Yano H, Tanaka H, Akagi Y, Okuda K.

Anticancer Res. 2019 Aug;39(8):4549-4554. doi: 10.21873/anticanres.13632.

PMID:
31366558
4.

Malic enzyme 1 is a potential marker of combined hepatocellular cholangiocarcinoma, subtype with stem-cell features, intermediate-cell type.

Mihara Y, Akiba J, Ogasawara S, Kondo R, Fukushima H, Itadani H, Obara H, Kakuma T, Kusano H, Naito Y, Okuda K, Nakashima O, Yano H.

Hepatol Res. 2019 Sep;49(9):1066-1075. doi: 10.1111/hepr.13365. Epub 2019 Jun 18.

PMID:
31077496
5.

Signal intensity of superb micro-vascular imaging associates with the activity of vascular inflammation in Takayasu arteritis.

Ito S, Tahara N, Hirakata S, Kaieda S, Tahara A, Maeda-Ogata S, Bekki M, Sugiyama Y, Honda A, Igata S, Kuromatsu R, Nakashima O, Fukumoto Y.

J Nucl Cardiol. 2019 Mar 4. doi: 10.1007/s12350-019-01665-4. [Epub ahead of print] No abstract available.

PMID:
30834495
6.

Inflammatory Hepatocellular Adenoma with Elevated Serum Protein Induced by Vitamin K Absence/Antagonist-II in Adult Males.

Koya Y, Suzuki T, Tai M, Ichii O, Matsuhashi N, Ejiri Y, Miyazawa M, Shibata M, Harada M, Kumabe T, Nakashima O.

Intern Med. 2019 Jun 15;58(12):1739-1746. doi: 10.2169/internalmedicine.1958-18. Epub 2019 Feb 25.

7.

[A Case of Advanced Gastric Cancer Who Peritoneal Dissemination but Survived over 40 Months with Locoregional Therapies].

Murayama M, Murakami S, Nakashima O, Yamazaki K, Koizumi K, Miyazawa M, Asaka S, Yamaguchi K, Yokomizo H, Shiozawa S, Yoshimatsu K, Shimakawa T, Katsube T, Naritaka Y.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2063-2065. Japanese.

PMID:
30692285
8.

Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey.

Fukami Y, Kaneoka Y, Maeda A, Kumada T, Tanaka J, Akita T, Kubo S, Izumi N, Kadoya M, Sakamoto M, Nakashima O, Matsuyama Y, Kokudo T, Hasegawa K, Yamashita T, Kashiwabara K, Takayama T, Kokudo N, Kudo M; Liver Cancer Study Group of Japan.

Ann Surg. 2019 Jan 16. doi: 10.1097/SLA.0000000000003192. [Epub ahead of print]

PMID:
30672806
9.

Intrabiliary growth type of metastasis from colon cancer, 12 years after curative colectomy: a case report.

Sasaki S, Nomura Y, Fukutomi S, Shirahama N, Kusano H, Akiba J, Sakai H, Hisaka T, Nakashima O, Yano H, Akagi Y, Tanaka H, Okuda K.

BMC Surg. 2019 Jan 18;19(1):8. doi: 10.1186/s12893-018-0466-4.

10.

Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method.

Tamaki N, Koizumi Y, Hirooka M, Yada N, Takada H, Nakashima O, Kudo M, Hiasa Y, Izumi N.

Hepatol Res. 2018 Sep;48(10):821-828. doi: 10.1111/hepr.13179. Epub 2018 May 18.

PMID:
29679473
11.

Treatment Optimization for Hepatocellular Carcinoma in Elderly Patients in a Japanese Nationwide Cohort.

Kaibori M, Yoshii K, Hasegawa K, Ogawa A, Kubo S, Tateishi R, Izumi N, Kadoya M, Kudo M, Kumada T, Sakamoto M, Nakashima O, Matsuyama Y, Takayama T, Kokudo N; Liver Cancer Study Group of Japan.

Ann Surg. 2019 Jul;270(1):121-130. doi: 10.1097/SLA.0000000000002751.

PMID:
29608544
12.

Granulocyte-colony stimulating factor producing mucinous cystic neoplasm with an associated invasive carcinoma of the pancreas.

Shimamatsu K, Naito Y, Mihara Y, Nakayama M, Tanigawa M, Abe Y, Nakamura K, Araki T, Sakata K, Noguchi K, Akiba J, Yano H, Nakashima O.

Oncol Lett. 2018 Feb;15(2):2387-2392. doi: 10.3892/ol.2017.7572. Epub 2017 Dec 8.

13.

Regulator of G-protein signaling 5 enhances portal vein invasion in hepatocellular carcinoma.

Umeno Y, Ogasawara S, Akiba J, Hattori S, Kusano H, Nakashima O, Koga H, Torimura T, Yamakawa R, Yano H.

Oncol Lett. 2018 Feb;15(2):1763-1770. doi: 10.3892/ol.2017.7474. Epub 2017 Nov 23.

14.

[A Case of Obstructive Jaundice Caused by Recurrent Gastric Cancer Previously Treated with Distal Gastrectomy and Roux-en-Y Reconstruction Whose Obstruction Was Relieved by ERCP for Altered Gastrointestinal Anatomy Using Conventional Endoscopes].

Murayama M, Murakami S, Nakashima O, Yamazaki K, Koizumi K, Shimazaki A, Yamaguchi K, Yokomizo H, Shiozawa S, Yoshimatsu K, Shimakawa T, Katsube T, Naritaka Y.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1808-1810. Japanese.

PMID:
29394783
15.

Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.

Takayasu K, Arii S, Sakamoto M, Matsuyama Y, Kudo M, Kaneko S, Nakashima O, Kadoya M, Izumi N, Takayama T, Ku Y, Kumada T, Kubo S, Kokudo T, Hagiwara Y, Kokudo N; Liver Cancer Study Group of Japan.

Liver Int. 2018 Mar;38(3):484-493. doi: 10.1111/liv.13670. Epub 2018 Jan 25.

PMID:
29266722
16.

Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function.

Hiraoka A, Michitaka K, Kumada T, Izumi N, Kadoya M, Kokudo N, Kubo S, Matsuyama Y, Nakashima O, Sakamoto M, Takayama T, Kokudo T, Kashiwabara K, Kudo M.

Liver Cancer. 2017 Nov;6(4):325-336. doi: 10.1159/000479984. Epub 2017 Sep 22.

17.

Diagnosis of Fibrosis and Activity by a Combined Use of Strain and Shear Wave Imaging in Patients with Liver Disease.

Yada N, Tamaki N, Koizumi Y, Hirooka M, Nakashima O, Hiasa Y, Izumi N, Kudo M.

Dig Dis. 2017;35(6):515-520. doi: 10.1159/000480140. Epub 2017 Oct 17.

PMID:
29040983
18.

Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey.

Kaibori M, Yoshii K, Yokota I, Hasegawa K, Nagashima F, Kubo S, Kon M, Izumi N, Kadoya M, Kudo M, Kumada T, Sakamoto M, Nakashima O, Matsuyama Y, Takayama T, Kokudo N; Liver Cancer Study Group of Japan.

Ann Surg. 2019 Apr;269(4):692-699. doi: 10.1097/SLA.0000000000002526.

PMID:
28922205
19.

Evaluation of hepatocellular carcinoma spread via the portal system by 3-dimensional mapping.

Fukutomi S, Nomura Y, Nakashima O, Yano H, Tanaka H, Akagi Y, Okuda K.

HPB (Oxford). 2017 Dec;19(12):1119-1125. doi: 10.1016/j.hpb.2017.08.011. Epub 2017 Sep 6.

20.

Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey.

Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, Kudo M, Kubo S, Sakamoto M, Nakashima O, Kumada T, Kokudo N; Liver Cancer Study Group of Japan.

Hepatology. 2017 Aug;66(2):510-517. doi: 10.1002/hep.29225. Epub 2017 Jun 26.

PMID:
28437844
21.

Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey.

Toyoda H, Tada T, Johnson PJ, Izumi N, Kadoya M, Kaneko S, Kokudo N, Ku Y, Kubo S, Kumada T, Matsuyama Y, Nakashima O, Sakamoto M, Takayama T, Kudo M; Liver Cancer Study Group of Japan.

J Gastroenterol. 2017 Oct;52(10):1112-1121. doi: 10.1007/s00535-017-1321-6. Epub 2017 Feb 21.

PMID:
28224228
22.

[A Case of Malignant Colonic Obstruction Bearing Another Synchronous Obstructive Lesion in the Anal Side of the Colon].

Murayama M, Nakashima O, Murakami S, Yamazaki K, Koizumi K, Shimazaki A, Asaka S, Yamaguchi K, Yokomizo H, Shiozawa S, Yoshimatsu K, Shimakawa T, Katsube T, Naritaka Y.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2283-2285. Japanese.

PMID:
28133296
23.

S-1 monotherapy in a patient with cholangiolocellular carcinoma: A case report.

Yamaguchi T, Seki T, Inokuchi R, Kawamura R, Murata M, Matsuzaki K, Nakashima O, Kumabe T, Okazaki K.

Mol Clin Oncol. 2016 Dec;5(6):762-766. doi: 10.3892/mco.2016.1049. Epub 2016 Oct 11.

24.

Malignant Transformation of Hepatocellular Adenoma.

Kwok WY, Hagiwara S, Nishida N, Watanabe T, Sakurai T, Ida H, Minami Y, Takita M, Minami T, Iwanishi M, Chishina H, Kono M, Ueshima K, Komeda Y, Arizumi T, Enoki E, Nakai T, Kumabe T, Nakashima O, Kondo F, Kudo M.

Oncology. 2017;92 Suppl 1:16-28. doi: 10.1159/000451012. Epub 2016 Dec 17.

25.

Clinicopathological features of neoplasms with neuroendocrine differentiation occurring in the liver.

Nomura Y, Nakashima O, Akiba J, Ogasawara S, Fukutomi S, Yamaguchi R, Kusano H, Kage M, Okuda K, Yano H.

J Clin Pathol. 2017 Jul;70(7):563-570. doi: 10.1136/jclinpath-2016-203941. Epub 2016 Nov 23.

PMID:
27881473
26.

Bile duct adenoma in patient with chronic hepatitis C: As a benign neoplasm by pathological and imaging studies.

Kim SK, Kim SR, Imoto S, Kim CW, Matsuoka T, Nakashima O, Sasaki M, Kumabe T, Kudo M, Fukusato T, Kondo F.

Pathol Int. 2016 Nov;66(11):640-642. doi: 10.1111/pin.12457. Epub 2016 Sep 23. No abstract available.

PMID:
27663997
27.

Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion.

Kokudo T, Hasegawa K, Matsuyama Y, Takayama T, Izumi N, Kadoya M, Kudo M, Ku Y, Sakamoto M, Nakashima O, Kaneko S, Kokudo N; Liver Cancer Study Group of Japan.

J Hepatol. 2016 Nov;65(5):938-943. doi: 10.1016/j.jhep.2016.05.044. Epub 2016 Jun 4.

PMID:
27266618
28.

Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan.

Kudo M, Izumi N, Sakamoto M, Matsuyama Y, Ichida T, Nakashima O, Matsui O, Ku Y, Kokudo N, Makuuchi M; Liver Cancer Study Group of Japan.

Liver Cancer. 2016 Jul;5(3):190-7. doi: 10.1159/000367775. Epub 2016 May 10.

29.

Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis.

Kitai S, Kudo M, Nishida N, Izumi N, Sakamoto M, Matsuyama Y, Ichida T, Nakashima O, Matsui O, Ku Y, Kokudo N, Makuuchi M; Liver Cancer Study Group of Japan.

Liver Cancer. 2016 Jul;5(3):175-89. doi: 10.1159/000367765. Epub 2016 May 3.

30.

Confluent hepatic fibrosis in alcohol liver cirrhosis with elevated pivkaii value - usefulness of immunostaining for EZH2 and p16(INK4a) in differentiating it from cholangiolocellular carcinoma - Confluent hepatic fibrosis.

Kim SK, Kim SR, Imoto S, Kim CW, Matsuoka T, Sasaki M, Nakashima O, Kumabe T, Hayashi Y.

Pathol Int. 2016 Sep;66(9):543-5. doi: 10.1111/pin.12435. Epub 2016 Jul 14. No abstract available.

PMID:
27418411
31.

Expression of HSP27 in Hepatocellular Carcinoma.

Eto D, Hisaka T, Horiuchi H, Uchida S, Ishikawa H, Kawashima Y, Kinugasa T, Nakashima O, Yano H, Okuda K, Akagi Y.

Anticancer Res. 2016 Jul;36(7):3775-9.

PMID:
27354654
32.

Diffusion-weighted magnetic resonance imaging predicts malignant potential in small hepatocellular carcinoma.

Okamura S, Sumie S, Tonan T, Nakano M, Satani M, Shimose S, Shirono T, Iwamoto H, Aino H, Niizeki T, Tajiri N, Kuromatsu R, Okuda K, Nakashima O, Torimura T.

Dig Liver Dis. 2016 Aug;48(8):945-52. doi: 10.1016/j.dld.2016.05.020. Epub 2016 Jun 1.

PMID:
27338850
33.

Malignant hepatic epithelioid angiomyolipoma with recurrence in the lung 7 years after hepatectomy: a case report and literature review.

Fukuda Y, Omiya H, Takami K, Mori K, Kodama Y, Mano M, Nomura Y, Akiba J, Yano H, Nakashima O, Ogawara M, Mita E, Nakamori S, Sekimoto M.

Surg Case Rep. 2016 Dec;2(1):31. doi: 10.1186/s40792-016-0158-1. Epub 2016 Apr 2.

34.

Report of the 19th follow-up survey of primary liver cancer in Japan.

Kudo M, Izumi N, Ichida T, Ku Y, Kokudo N, Sakamoto M, Takayama T, Nakashima O, Matsui O, Matsuyama Y.

Hepatol Res. 2016 Mar;46(5):372-90. doi: 10.1111/hepr.12697.

PMID:
26970231
35.

The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type.

Akiba J, Nakashima O, Hattori S, Naito Y, Kusano H, Kondo R, Nakayama M, Tanikawa K, Todoroki K, Umeno Y, Nakamura K, Sanada S, Yamaguchi R, Ogasawara S, Yano H.

J Clin Pathol. 2016 Oct;69(10):846-51. doi: 10.1136/jclinpath-2015-203491. Epub 2016 Mar 11.

PMID:
26969740
36.

[Analysis of Palliative Stent Placement for Acute Malignant Colorectal Obstruction].

Murayama M, Nakashima O, Yamazaki K, Koizumi K, Shimazaki A, Asaka S, Yamaguchi K, Yokomizo H, Shiozawa S, Yoshimatsu K, Shimakawa T, Katsube T, Naritaka Y.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1540-2. Japanese.

PMID:
26805089
37.

Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan.

Sakamoto Y, Kokudo N, Matsuyama Y, Sakamoto M, Izumi N, Kadoya M, Kaneko S, Ku Y, Kudo M, Takayama T, Nakashima O; Liver Cancer Study Group of Japan.

Cancer. 2016 Jan 1;122(1):61-70. doi: 10.1002/cncr.29686. Epub 2015 Oct 2.

38.

Neoplastic spindle cells are an independent prognostic factor in pancreatic cancer.

Takahashi K, Hisaka T, Horiuchi H, Ishikawa H, Nakayama M, Nakashima O, Kawahara A, Kage M, Yano H, Akagi Y, Yonemoto K, Kinoshita H, Shirouzu K.

Pancreas. 2015 Jul;44(5):742-9. doi: 10.1097/MPA.0000000000000337.

PMID:
25931259
39.

Des-γ-carboxyprothrombin (DCP) and NX-DCP expressions and their relationship with clinicopathological features in hepatocellular carcinoma.

Sumi A, Akiba J, Ogasawara S, Nakayama M, Nomura Y, Yasumoto M, Sanada S, Nakashima O, Abe T, Yano H.

PLoS One. 2015 Mar 4;10(3):e0118452. doi: 10.1371/journal.pone.0118452. eCollection 2015.

40.

[The case of a patient who experienced perforation related to sigmoid colon cancer, was bearing a hepatic metastasis, and who underwent radical resection for advanced colon cancer after a salvage operation for pan-peritonitis and chemotherapy].

Murayama M, Nakashima O, Yamazaki K, Koizumi K, Miyauchi T, Miyaki A, Usuda A, Yamaguchi K, Yokomizo H, Shiozawa S, Yoshimatsu K, Shimakawa T, Katsube T, Naritaka Y.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1782-4. Japanese.

PMID:
25731328
41.

Clinicopathologic analysis of the simple nodular type of well-differentiated hepatocellular carcinoma with extensive peliotic change.

Nomura Y, Nakashima O, Kumabe T, Akiba J, Ogasawara S, Kage M, Kinoshita H, Yano H.

J Gastroenterol Hepatol. 2014;29(7):1494-99. No abstract available.

PMID:
25587618
42.

Noninvasive diagnosis of liver fibrosis: utility of data mining of both ultrasound elastography and serological findings to construct a decision tree.

Yada N, Kudo M, Kawada N, Sato S, Osaki Y, Ishikawa A, Miyoshi H, Sakamoto M, Kage M, Nakashima O, Tonomura A.

Oncology. 2014;87 Suppl 1:63-72. doi: 10.1159/000368147. Epub 2014 Nov 22.

PMID:
25427735
43.

Validation of three staging systems for hepatocellular carcinoma (JIS score, biomarker-combined JIS score and BCLC system) in 4,649 cases from a Japanese nationwide survey.

Kitai S, Kudo M, Izumi N, Kaneko S, Ku Y, Kokudo N, Sakamoto M, Takayama T, Nakashima O, Kadoya M, Matsuyama Y, Matsunaga T.

Dig Dis. 2014;32(6):717-24. doi: 10.1159/000368008. Epub 2014 Oct 29.

PMID:
25376289
44.

Therapeutic efficacy of splenectomy is attenuated by necroinflammation of the liver in patients with liver cirrhosis.

Kondo R, Kage M, Ogata T, Nakashima O, Akiba J, Nomura Y, Yano H.

J Hepatobiliary Pancreat Sci. 2015 Mar;22(3):217-24. doi: 10.1002/jhbp.177. Epub 2014 Oct 23.

PMID:
25345682
45.

Epithelial cell adhesion molecule-positive human hepatic neoplastic cells: development of combined hepatocellular-cholangiocarcinoma in mice.

Ogasawara S, Akiba J, Nakayama M, Nakashima O, Torimura T, Yano H.

J Gastroenterol Hepatol. 2015 Feb;30(2):413-20. doi: 10.1111/jgh.12692.

PMID:
25087473
46.

A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.

Utsunomiya T, Shimada M, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Takayama T, Kokudo N; Liver Cancer Study Group of Japan.

Ann Surg. 2015 Mar;261(3):513-20. doi: 10.1097/SLA.0000000000000821.

PMID:
25072437
47.

Pegylated interferon-α2a inhibits proliferation of human liver cancer cells in vitro and in vivo.

Kusano H, Akiba J, Ogasawara S, Sanada S, Yasumoto M, Nakayama M, Ueda K, Ueda K, Kurita T, Todoroki K, Umeno Y, Nakashima O, Yano H.

PLoS One. 2013 Dec 12;8(12):e83195. doi: 10.1371/journal.pone.0083195. eCollection 2013.

48.

The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.

Sumie S, Nakashima O, Okuda K, Kuromatsu R, Kawaguchi A, Nakano M, Satani M, Yamada S, Okamura S, Hori M, Kakuma T, Torimura T, Sata M.

Ann Surg Oncol. 2014 Mar;21(3):1002-9. doi: 10.1245/s10434-013-3376-9. Epub 2013 Nov 20.

PMID:
24254204
49.

Infantile hemangioma of the liver in an adult: a case report and review of the literature.

Sumi A, Akiba J, Nagata S, Tonan T, Nomura Y, Ogata T, Uchida M, Nakashima O, Kage M, Yano H.

Mol Med Rep. 2014 Jan;9(1):23-7. doi: 10.3892/mmr.2013.1749. Epub 2013 Oct 22. Review.

PMID:
24145896
50.

Perioperative challenges and surgical treatment of large simple, and infectious liver cyst - a 12-year experience.

Maruyama Y, Okuda K, Ogata T, Yasunaga M, Ishikawa H, Hirakawa Y, Fukuyo K, Horiuchi H, Nakashima O, Kinoshita H.

PLoS One. 2013 Oct 2;8(10):e76537. doi: 10.1371/journal.pone.0076537. eCollection 2013. Review.

Supplemental Content

Loading ...
Support Center